C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2004
10/14/2004	US20040204422 N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
10/14/2004	US20040204420 Compounds for modulating RNA interference
10/14/2004	US20040204415 Pyrrolo[1,2-B]pyridazine compounds and their uses
10/14/2004	US20040204414 Pyrrolo[1,2-B]pyridazine compounds and their uses
10/14/2004	US20040204400 Anti-enterovirus compounds
10/14/2004	US20040204347 administering an effective amount of an inhibitor of the interaction of glutamate with the alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor complex to treat demyelinating disorders
10/14/2004	US20040204257 System for and a method of manufacturing personal golf putters
10/14/2004	US20040202930 New electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators
10/14/2004	US20040202876 Photoelectric conversion; efficiency, reduced energy loss
10/14/2004	US20040202617 Delivery of opioids through an inhalation route
10/14/2004	DE10315572A1 Substituierte Pyrazole Substituted pyrazoles
10/14/2004	CA2521191A1 Pyrrolo (1,2-b) pyridazine compounds and their use as cfr-1 receptor antagonists
10/14/2004	CA2520997A1 Salts of tricyclic inhibitors of poly(adp-ribose) polymerases
10/14/2004	CA2520900A1 Pyrrolo[1,2-b]pyridazine compounds and their use as crf1 receptor antagonists
10/14/2004	CA2520899A1 Pyrrolo[1,2-b]pyridazine compounds and their uses
10/14/2004	CA2520896A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
10/14/2004	CA2520718A1 7-alkinylamino-triazolopyrimidines, methods for the production and use thereof to combat harmful fungi and agents containing said compounds
10/14/2004	CA2520579A1 7-alkenylamino-triazolopyrimidines, method for the production thereof and use thereof in controlling harmful fungi and substances containing said triazolopyrimidines
10/14/2004	CA2520465A1 Bi-cyclic pyrimidine inhibitors of tgf.beta.
10/14/2004	CA2518465A1 Dipeptidyl peptidase inhibitors
10/13/2004	EP1466915A1 Porphyrin compound, albumin inclusion compound thereof and artificial oxygen carrier
10/13/2004	EP1466914A1 Amorphous substance of tricyclic triazolobenzazepine derivative
10/13/2004	EP1466911A2 Preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
10/13/2004	EP1466598A2 PDE-IV inhibitors
10/13/2004	EP1466527A1 Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method of controlling weed with the same
10/13/2004	EP1465885A2 Novel alkyl/aryl hydroxy or keto thiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
10/13/2004	EP1465878A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors
10/13/2004	EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto
10/13/2004	EP1465838A2 A process for the microbiological decontamination of water by means of photosensitive agents
10/13/2004	EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
10/13/2004	EP1465625A2 Solubilized topoisomerase poisons
10/13/2004	EP1465617A1 Process for affecting neurologic progression
10/13/2004	EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/13/2004	EP1280771B1 Novel prodrugs von 6-hydroxy-2,3-dihydro-1h-indoles, 5-hydroxy-1,2-dihydro-3h-pyrrolo 3,2-e]indoles and 5-hydroxy-1,2-dihydro-3h-benzo(e)indoles as well as of 6-hydroxy-1,2,3,4-tetrahydro-benzo f]quinoline derivatives for use in selective cancer therapy
10/13/2004	EP1261346A4 Modulation of cardiovascular injury
10/13/2004	EP1185529B1 Pyrazolobenzodiazepines as cdk2 inhibitors
10/13/2004	EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands
10/13/2004	CN1537113A Process for production of N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide (zaleplom)
10/13/2004	CN1537004A Compositions containing imidazotriazinone for nasal application
10/13/2004	CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators
10/13/2004	CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative
10/13/2004	CN1535958A Alpha-substituted pyrimidine. thioalkyl and alkyl ether compound
10/13/2004	CN1535682A Medicine for improved bladder excretion capacity
10/13/2004	CN1170829C Optically active pyrrolopyridazine compound
10/13/2004	CN1170813C N2 phenylamidine derivatives and fungicidal composition and use
10/12/2004	US6803463 Process for the preparation of pyrazolopyridine derivatives
10/12/2004	US6803455 Inhibitors of nucleoside metabolism
10/12/2004	US6803384 Diaminopropionic acid derivatives
10/12/2004	US6803365 Imidazo[1,3,5]triazinones and the use thereof
10/12/2004	US6803031 Aerosol comprises particles comprising at least 10 percent by weight of an erectile dysfunction drug, such as sildenafil, tadalafil or vardenafil.
10/07/2004	WO2004085661A2 Process to chiral beta-amino acid derivatives
10/07/2004	WO2004085439A1 Substituted 4-amino[1,2,4]triazolo[4,3-a]quinoxalines
10/07/2004	WO2004085438A2 Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents
10/07/2004	WO2004085425A1 Fused azoles such as 2,5-disubstituted benzimidazoles, benzoxazoles and benzothiazoles as kinase inhibitors
10/07/2004	WO2004085409A2 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof
10/07/2004	WO2004085387A2 Water-soluble mono-pegylated tetrapyrrole derivatives for photodynamic therapy and method of production
10/07/2004	WO2004085378A1 Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation
10/07/2004	WO2004084901A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
10/07/2004	WO2004084898A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/07/2004	WO2004084817A2 Siderophore conjugates of photoactive dyes for photodynamic therapy
10/07/2004	WO2004084809A2 Neuroprotective macrocylic compounds and methods for their use
10/07/2004	WO2004076384A3 Protection of amine and hydroxyl groups using fluoroacylation
10/07/2004	WO2004054514A3 C-6 modified indazolylpyrrolotriazines
10/07/2004	WO2003105770A3 Carbocyclic nucleoside analogs as rna-antivirals
10/07/2004	WO2003076427A8 Quinazoline compounds useful in therapy
10/07/2004	WO2003053973A8 Pyrazolyl-substituted triazoloquinoxalines
10/07/2004	WO2003049679A3 Mitotic kinesin inhibitors
10/07/2004	US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis
10/07/2004	US20040198976 Method for synthesizing pyrazolobenzodiazepines
10/07/2004	US20040198974 applying deemed racemates to continuos enantioselective liquid chromatography like SMB (simulated moving bed); for industrial scale production of pure enantiomers of amino acids useful as intermediates in organic synthesis such as N-benzyloxycarbonyl-tert-leucine
10/07/2004	US20040198945 Polymerization of aromatic monomers using derivatives of hematin
10/07/2004	US20040198797 cyclization, condensation of arylmalonic acid diamine with hydrazine forming 3-hydroxy-4-aryl-5-oxopyrazoline
10/07/2004	US20040198781 Carbonic anhydrase inhibitor
10/07/2004	US20040198751 Pyrazolo-pyrimidine compound; anticancer agents
10/07/2004	US20040198738 Preventives or remedies for diseaes caused by enos expression
10/07/2004	US20040198737 Azaindoles
10/07/2004	US20040198726 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
10/07/2004	US20040198724 Contacting a cell with a quinazolinones containing sulfur or its oxides in an amount sufficient to open the potassium channels for the treatment of central or peripheral nervous system disorders
10/07/2004	US20040198722 Pyrrolobenzodiazepines on solid supports;
10/07/2004	US20040198717 4-(trifluoromethyl)-7,8,9,10-tetrahydrochromeno[7,6-b]azepin-2(6H)-one and derivatives;4-(trifluoromethyl)-1,6,7,8,9,10-hexahydro-2H-azepino[3,2-g]quinolin-2-one and derivatives; useful in the treating conditions caused by androgen deficiency such as bone disorders
10/07/2004	US20040194227 Pyrrolidinyl-substituted para-phenylenediamine derivatives substituted with a cationic radical, and use of these derivatives for dyeing keratin fibres
10/07/2004	CA2520440A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
10/07/2004	CA2520251A1 Substituted 4-amino[1,2,4]triazolo[4,3-a]quinoxalines
10/07/2004	CA2518909A1 Heterocyclic compounds and methods of use
10/06/2004	EP1464645A1 Indole derivative
10/06/2004	EP1463742A2 Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
10/06/2004	EP1463732A1 Hydroxycucurbituril derivatives, their preparation methods and uses
10/06/2004	EP1463731A1 Dibenzodiazepine derivates, their preparation and use
10/06/2004	EP1463730A1 Pyrazoloparidazine derivatives
10/06/2004	EP1463729A1 A process for producing phenserine and its analog
10/06/2004	EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function
10/06/2004	EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists
10/06/2004	EP1353923B1 Improved process for carbapenem synthesis
10/06/2004	EP1248787B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
10/06/2004	EP1144414B1 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
10/06/2004	EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors
10/06/2004	EP0904075B1 Method for treating viral infections
10/06/2004	CN1535273A Novel 2,5-diazabicyclo [2.2.1] heptane derivatives
10/06/2004	CN1535113A 7-amino triazolopyrimidines for controlling harmful fungi
10/06/2004	CN1534015A Preparation method of 2-(2-arylmorpholine-2-yl)-ethanol and intermediate

1 ... 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 ... 573